المؤلفون: Sivapalan P; Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark. Pradeesh.s@dadlnet.dk., Ulrik CS; Amager and Hvidovre Hospital, University of Copenhagen, Copenhagen, Denmark., Lappere TS; Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark., Eklöf JV; Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark., Shaker SB; Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark., Bødtger UCS; Næstved, Slagelse and Ringsted Hospitals, University of Southern Denmark, Odense, Denmark., Browatzki A; Nordsjællands Hospital Hillerød, University of Copenhagen, Hillerød, Denmark., Meyer CN; Zeeland University Hospital, Roskilde, Denmark., Weinreich UM; Aalborg University Hospital, Aalborg University, Aalborg, Denmark., Laursen CB; Odense University Hospital, University of Southern Denmark, Odense, Denmark., Biering-Sørensen T; Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark., Knop FK; Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark., Lundgren JD; Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Jensen JS; Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.

المصدر: Trials [Trials] 2020 Oct 20; Vol. 21 (1), pp. 867. Date of Electronic Publication: 2020 Oct 20.

نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Bacterial Agents/*therapeutic use , Antimalarials/*therapeutic use , Azithromycin/*therapeutic use , Betacoronavirus/*drug effects , Coronavirus Infections/*prevention & control , Hydroxychloroquine/*therapeutic use , Pandemics/*prevention & control , Pneumonia, Viral/*prevention & control, Aged ; Anti-Bacterial Agents/adverse effects ; Antibiotic Prophylaxis/methods ; Antimalarials/adverse effects ; Azithromycin/adverse effects ; Betacoronavirus/genetics ; COVID-19 ; Case-Control Studies ; Coronavirus Infections/epidemiology ; Coronavirus Infections/transmission ; Coronavirus Infections/virology ; Denmark/epidemiology ; Double-Blind Method ; Drug Therapy, Combination ; Female ; Hospital Mortality/trends ; Hospitalization/statistics & numerical data ; Humans ; Hydroxychloroquine/adverse effects ; Intensive Care Units/statistics & numerical data ; Intention to Treat Analysis/methods ; Male ; Noninvasive Ventilation/adverse effects ; Placebos/administration & dosage ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/transmission ; Pneumonia, Viral/virology ; Risk Reduction Behavior ; SARS-CoV-2

المؤلفون: Sivapalan P; Section of Respiratory Medicine, Department of Medicine, Herlev and Gentofte Hospital University of Copenhagen, Hellerup, Denmark.; Department of Internal Medicine, Zealand University Hospital, Roskilde, Denmark., Ulrik CS; Department of Respiratory Medicine, Amager and Hvidovre Hospital University of Copenhagen, Hvidovre, Denmark., Bojesen RD; Department of Surgery, Næstved-Slagelse- Ringsted Hospitals University of Southern Denmark, Slagelse, Denmark., Lapperre TS; Department of Respiratory Medicine, Bispebjerg and Frederiksberg Hospital University of Copenhagen, Copenhagen, Denmark., Eklöf JV; Section of Respiratory Medicine, Department of Medicine, Herlev and Gentofte Hospital University of Copenhagen, Hellerup, Denmark., Håkansson KEJ; Department of Respiratory Medicine, Amager and Hvidovre Hospital University of Copenhagen, Hvidovre, Denmark., Browatzki A; Department of Respiratory and Infectious Diseases, Nordsjællands Hospital University of Copenhagen, Hillerød, Denmark., Tidemansen C; Department of Respiratory Medicine, Amager and Hvidovre Hospital University of Copenhagen, Hvidovre, Denmark., Wilcke JT; Section of Respiratory Medicine, Department of Medicine, Herlev and Gentofte Hospital University of Copenhagen, Hellerup, Denmark., Janner J; Department of Respiratory Medicine, Amager and Hvidovre Hospital University of Copenhagen, Hvidovre, Denmark., Gottlieb V; Section of Respiratory Medicine, Department of Medicine, Herlev and Gentofte Hospital University of Copenhagen, Hellerup, Denmark., Meteran H; Section of Respiratory Medicine, Department of Medicine, Herlev and Gentofte Hospital University of Copenhagen, Hellerup, Denmark., Porsbjerg C; Department of Respiratory Medicine, Bispebjerg and Frederiksberg Hospital University of Copenhagen, Copenhagen, Denmark., Madsen BL; Department of Respiratory and Infectious Diseases, Nordsjællands Hospital University of Copenhagen, Hillerød, Denmark., Moberg M; Department of Respiratory Medicine, Amager and Hvidovre Hospital University of Copenhagen, Hvidovre, Denmark., Pedersen L; Department of Respiratory Medicine, Bispebjerg and Frederiksberg Hospital University of Copenhagen, Copenhagen, Denmark., Benfield TL; Dep. of Infectious Diseases, Amager and Hvidovre Hospital University of Copenhagen, Hvidovre, Denmark., Lundgren JD; Department of Infectious Diseases, Rigshospitalet University of Copenhagen, Copenhagen, Denmark., Knop FK; Department of Clinical Metabolic Research, Herlev and Gentofte Hospital University of Copenhagen, Hellerup, Denmark., Biering-Sørensen T; Department of Cardiology, Herlev and Gentofte Hospital University of Copenhagen, Hellerup, Denmark., Ghanizada M; Department of Respiratory Medicine, Bispebjerg and Frederiksberg Hospital University of Copenhagen, Copenhagen, Denmark., Sonne TP; Section of Respiratory Medicine, Department of Medicine, Herlev and Gentofte Hospital University of Copenhagen, Hellerup, Denmark., Bødtger UCS; Department of Internal Medicine, Zealand University Hospital, Roskilde, Denmark.; Department of Respiratory Medicine, Næstved-Slagelse-Ringsted Hospitals University of Southern Denmark, Slagelse, Denmark.; Institute for Regional Health Research University of Southern Denmark, Odense, Denmark., Jensen SG; Section of Respiratory Medicine, Department of Medicine, Herlev and Gentofte Hospital University of Copenhagen, Hellerup, Denmark., Rasmussen DB; Department of Respiratory Medicine, Næstved-Slagelse-Ringsted Hospitals University of Southern Denmark, Slagelse, Denmark., Brøndum E; Department of Respiratory Medicine, Amager and Hvidovre Hospital University of Copenhagen, Hvidovre, Denmark., Tupper OD; Department of Respiratory Medicine, Amager and Hvidovre Hospital University of Copenhagen, Hvidovre, Denmark., Sørensen SW; Department of Respiratory Medicine, Amager and Hvidovre Hospital University of Copenhagen, Hvidovre, Denmark., Alstrup G; Department of Respiratory Medicine, Næstved-Slagelse-Ringsted Hospitals University of Southern Denmark, Slagelse, Denmark., Laursen CB; Department of Respiratory Medicine, Odense University Hospital University of Southern Denmark, Odense, Denmark., Møller UW; Department of Respiratory Medicine, Aalborg University Hospital University of Aalborg, Aalborg, Denmark., Sverrild A; Department of Respiratory Medicine, Bispebjerg and Frederiksberg Hospital University of Copenhagen, Copenhagen, Denmark., Jensen JS; Section of Respiratory Medicine, Department of Medicine, Herlev and Gentofte Hospital University of Copenhagen, Hellerup, Denmark. jens.ulrik.jensen@regionh.dk.

المصدر: Trials [Trials] 2020 Jun 10; Vol. 21 (1), pp. 513. Date of Electronic Publication: 2020 Jun 10.

نوع المنشور: Clinical Trial Protocol; Letter

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE

مواضيع طبية MeSH: Inpatients* , Patient Admission*, Antiviral Agents/*administration & dosage , Azithromycin/*administration & dosage , Betacoronavirus/*drug effects , Coronavirus Infections/*drug therapy , Hydroxychloroquine/*administration & dosage , Pneumonia, Viral/*drug therapy, Antiviral Agents/adverse effects ; Azithromycin/adverse effects ; Betacoronavirus/pathogenicity ; COVID-19 ; Coronavirus Infections/diagnosis ; Coronavirus Infections/mortality ; Coronavirus Infections/virology ; Critical Care ; Denmark ; Double-Blind Method ; Drug Administration Schedule ; Hospital Mortality ; Host-Pathogen Interactions ; Humans ; Hydroxychloroquine/adverse effects ; Length of Stay ; Multicenter Studies as Topic ; Noninvasive Ventilation ; Pandemics ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/mortality ; Pneumonia, Viral/virology ; Randomized Controlled Trials as Topic ; SARS-CoV-2 ; Severity of Illness Index ; Time Factors ; Treatment Outcome ; COVID-19 Drug Treatment